Buscar
Mostrando ítems 1-10 de 367
CRISPR/Cas13: A potential therapeutic option of COVID-19
The novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
can be considered as the most important current global issue, as it has caused the novel
coronavirus disease (COVID-19) pandemic, ...
CRISPR-Cas13d Induces Efficient mRNA Knockdown in Animal Embryos
(Elsevier, 2020)
The development of mRNA knockdown technologies for use in vertebrate organisms such as zebrafish has been limited. Kushawah et al. establish CRISPR-RfxCas13d as an efficient, specific, cost-effective, and straightforward ...
CRISPR / Cas: the future of genetic editingCRISPR/CAS: EL FUTURO DE LA EDICIÓN GENÉTICA
(Universida de Sonora, 2019)
CRISPR / CAS: the future of gene editingCRISPR/CAS: EL FUTURO DE LA EDICIÓN GENÉTICA
(Universida de Sonora, 2020)
Terapia fágica e entrega de sistemas CRISPR-Cas9 Tipo II programáveis como alternativa ao uso de antibióticos no combate a Staphylococcus aureus: revisão sistemática da literatura
(Universidade Federal de São CarlosUFSCarCâmpus São CarlosBiotecnologia - Biotec, 2022-09-26)
Staphylococcus aureus is a commensal bacterium of both the skin and the human mucosa, but also a frequent cause of serious infections with high morbidity, mortality and associated health costs. S. aureus strains have the ...
CRISPR/Cas9 y la terapia génicaCRISPR/Cas9 and gene therapy
(Medicina (Buenos Aires), 2017-10)
El desarrollo de técnicas que permitan editar o corregir con precisión y eficiencia el genoma de células vivas es uno de los objetivos principales de la investigación biomédica. En las últimas décadas se han investigado e ...